Richard C Malabre Akebia Therapeutics, Inc. (AKBA) insider trading activity

AKBA Quotes by TradingView

Richard C Malabre is SVP, Chief Accounting Officer of Akebia Therapeutics, Inc.. Currently has a direct ownership of 266,914 shares of AKBA, which is worth approximately $984,912. The most recent transaction as insider was on Jun 09, 2025, when has been sold 15,000 shares (Common Stock) at a price of $4.01 per share, resulting in proceeds of $60,150. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 267K
4.76% 3M change
19.18% 12M change
Total Value Held $984,912

Richard C Malabre Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 09 2025
SELL
Open market or private sale
$60,150 $4.01 p/Share
15,000 Reduced 5.32%
266,914 Common Stock
Jun 09 2025
BUY
Exercise of conversion of derivative security
$25,200 $1.68 p/Share
15,000 Added 5.05%
281,914 Common Stock
Jun 04 2025
SELL
Open market or private sale
$47,069 $3.53 p/Share
13,334 Reduced 4.76%
266,914 Common Stock
Feb 03 2025
SELL
Open market or private sale
$63,424 $2.1 p/Share
30,202 Reduced 9.73%
280,248 Common Stock
Jan 31 2025
BUY
Grant, award, or other acquisition
-
85,000 Added 21.49%
310,450 Common Stock
Jan 31 2024
BUY
Grant, award, or other acquisition
-
223,950 Added 50.0%
223,950 Common Stock
RCM

Richard C Malabre

SVP, Chief Accounting Officer
Cambridge, MA

Track Institutional and Insider Activities on AKBA

Follow Akebia Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AKBA shares.

Notify only if

Insider Trading

Get notified when an Akebia Therapeutics, Inc. insider buys or sells AKBA shares.

Notify only if

News

Receive news related to Akebia Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AKBA